EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Bio-Gate AG's enterprise value is €9.67 Mil.
Bio-Gate AG's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €7.25 Mil. Therefore, Bio-Gate AG's EV-to-Revenue for today is 1.33.
The historical rank and industry rank for Bio-Gate AG's EV-to-Revenue or its related term are showing as below:
XTER:BIG1'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.46 Med: 3.21 Max: 9.7
Current: 1.34
During the past 13 years, the highest EV-to-Revenue of Bio-Gate AG was 9.70. The lowest was 0.46. And the median was 3.21.
XTER:BIG1's EV-to-Revenue is ranked better than 76.61% of 825
companies
in the Medical Devices & Instruments industry
Industry Median: 3.06
vs XTER:BIG1: 1.34
As of today (2024-06-19), Bio-Gate AG's stock price is €1.08.
Bio-Gate AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.82. Therefore, Bio-Gate AG's PS Ratio for today is 1.32.
Bio-Gate AG EV-to-Revenue Historical Data
The historical data trend for Bio-Gate AG's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Bio-Gate AG's EV-to-Revenue
For the Medical Instruments & Supplies subindustry, Bio-Gate AG's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio-Gate AG's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bio-Gate AG's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Bio-Gate AG's EV-to-Revenue falls into.
Bio-Gate AG's current Enterprise Value is €9.67 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Bio-Gate AG's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €7.25 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bio-Gate AG's share price for today is €1.08.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was €0.82.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bio-Gate AG EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Bio-Gate AG's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Bio-Gate AG is a Germany based medical technology company. The company employs silver technology to endow materials and products with antimicrobial properties. It is focused on the medical technology products portfolio. In addition, its technologies are also used to refine cosmetics, consumer goods, and industrial products. The products of the company are plasma-coating, additives, textile solutions, spray, masterbatches, and others. The organization uses two different technologies; first, silver particles are incorporated into cosmetics, paints, veneers or plastics, and second involve coating final products like implants or wound dressings with a silver-containing functional layer.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XTER:BIG1 has been successfully added to your 